• Latest Posts

The Billion-Euro European Biotech Companies in 2022

A Year to Remember: The Biggest European Biotech News in 2020

Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia

Top Cardiology Biotech News from the ESC Conference 2019

More News! 18 Jun 2018

Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage


Actelion’s Billion-Euro Spin-Off Starts First Phase III Trial in its Pipeline

How is Actelion Spin-Off Idorsia Doing One Year Later?

Actelion Spin Out and Roche Join Forces to Develop Cancer Immunotherapies

Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III